Literature DB >> 6130950

Immunopathology of ulcerative colitis and Crohn's disease, nonsurgical therapeutic considerations.

F Bläker, K H Schäfer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6130950     DOI: 10.1007/bf01377348

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  36 in total

1.  Immunological studies in patients with Crohn's disease.

Authors:  B R MacPherson; R J Albertini; W L Beeken
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

2.  C3 metabolism in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

3.  Secretory immunoglobulin deficiency in a family with inflammatory bowel disease.

Authors:  J F Engstrom; C Arvanitakis; A Sagawa; N I Abdou
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

4.  Azathioprine has a very limited role in the treatment of Crohn's disease.

Authors:  J W Singleton
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

5.  Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.

Authors:  U Klotz; K Maier; C Fischer; K Heinkel
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

6.  Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease.

Authors:  J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

7.  The pathogenesis of Crohn's disease.

Authors:  M Ward
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

8.  Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis.

Authors:  S Meyers; D B Sacher; R N Taub; H D Janowitz
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

9.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

10.  Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.

Authors:  G Bendixen
Journal:  Gut       Date:  1969-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.